EP Biocomposites Ltd
BSE: 543595
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q4 FY25 | Q2 FY25 | Q4 FY24 | Q2 FY24 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 4.08-46.4% | 7.60+72.6% | 4.41-37.4% | 7.04+60.1% | 4.40 |
| Other Income | 0.07+16.1% | 0.06+31.9% | 0.05-77.7% | 0.21+139.8% | 0.09 |
| Total Income | 4.15-45.9% | 7.66+72.1% | 4.45-38.6% | 7.25+61.6% | 4.49 |
| EXPENSES | |||||
| Expenditure | 4.03-38.6% | 6.56+58.3% | 4.14-30.7% | 5.98+42.7% | 4.19 |
| Tax | 0.03-89.3% | 0.28+167.6% | 0.10-69.6% | 0.34+353.9% | 0.08 |
| PROFIT | |||||
| PBT | 0.12-89.1% | 1.11+255.6% | 0.31-75.6% | 1.27+328.6% | 0.30 |
| Net Profit | 0.09-89.1% | 0.82+300.5% | 0.21-77.8% | 0.93+320.4% | 0.22 |
| KEY METRICS | |||||
| OPM % | -3.61%-14.15pp | 10.54%+9.63pp | 0.91%-13.08pp | 13.99%+10.58pp | 3.41% |
| NPM % | 2.17%-8.59pp | 10.76%+6.13pp | 4.63%-8.18pp | 12.81%+7.88pp | 4.93% |
| EPS | 0.51-89.6% | 4.91+302.5% | 1.22-71.0% | 4.21+218.9% | 1.32 |
Corporate Events
Board MeetingEPBIO
202613Nov
Board Meeting
The meeting of the Board of Directors is scheduled to be hel…
BSE Filing ↗ Board MeetingEPBIO
202628Sep
Board Meeting
The Seventh Annual General Meeting of the Members of EP Bioc…
BSE Filing ↗ Board MeetingEPBIO
202626May
Board Meeting
The board meeting is scheduled to consider and approve the d…
BSE Filing ↗ Board MeetingEPBIO
202523May
Board Meeting
Consideration of the Financial Statements for year ended Mar…
BSE Filing ↗ Board MeetingEPBIO
202413Nov
Board Meeting
Consideration Of The Financial Results For The Half-Year End…
BSE Filing ↗ Board MeetingEPBIO
202424May
Board Meeting
approval of financial results for year ended March 31, 2024
BSE Filing ↗